1995
DOI: 10.1590/s0036-46651995000500003
|View full text |Cite
|
Sign up to set email alerts
|

Interferon gamma increases survival in urine experimental cryptococcosis

Abstract: Systemic disease by Cryptococcus neoformans (C. neoformans) is a common opportunistic infection in immunodeficient patients. Cellular immunity seems to be the most important determinant of resistance. The aim of this study was to assess the effect of recombinant rat interferon gamma (IFN-gamma) in murine cryptococcosis (Balb/c mice infected by IP route with the Rivas strain of C. neoformans), evaluating survival time, macroscopic and microscopic examination of the organs, and massive seeding of brain homogenat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
6
0

Year Published

2007
2007
2016
2016

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 14 publications
0
6
0
Order By: Relevance
“…However, there seem to be differences in IFN-␥-related signaling in mice and humans. IFN-␥ has clearly been demonstrated to have a protective role in mouse model systems of cryptococcosis (5,24) and to increase fungicidal activity of murine macrophages (19). However, among human cells, IFN-␥ treatment reduces the capacity of human alveolar macrophages (44) and human monocyte-derived macrophages (30) to inhibit cryptococcal growth, a finding that is supported by our data.…”
Section: Discussionmentioning
confidence: 99%
“…However, there seem to be differences in IFN-␥-related signaling in mice and humans. IFN-␥ has clearly been demonstrated to have a protective role in mouse model systems of cryptococcosis (5,24) and to increase fungicidal activity of murine macrophages (19). However, among human cells, IFN-␥ treatment reduces the capacity of human alveolar macrophages (44) and human monocyte-derived macrophages (30) to inhibit cryptococcal growth, a finding that is supported by our data.…”
Section: Discussionmentioning
confidence: 99%
“…IFN-␥ is able to cross the BBB and persist in the brain at very low concentrations (42), and the biological effects of IFN-␥ are largely restrained by immunosuppressive factors in the brain such as TGF-␤ and IL-10 (54). IFN-␥ as single regimen has shown a limited therapeutic effect on cryptococcosis (55,56), and the amount of IFN-␥ given systemically is limited by the severe toxicity observed (57). The benefit of anti-CD40/IL-2 treatment was to stimulate immune cells to produce IFN-␥ at a physiologically effective level without this toxicity.…”
Section: Discussionmentioning
confidence: 99%
“…Lysates were then treated with collagenase A (1 mg/ml; Boehringer Mannheim, Chicago, IL) in digestion buffer (RPMI medium, 10% fetal calf serum) and incubated for 1 h at 37°C with occasional shaking. Cells were centrifuged and suspended in 0.17 M NH 4 Cl to lyse erythrocytes for 10 min at 4°C. A 10-fold excess of RPMI solution was then added to make the solution isotonic, and the cells were collected by centrifugation and suspended in staining buffer (PBS, 1% fetal bovine serum).…”
Section: Yeast Strain and Preparation Of Inocula For Infectionmentioning
confidence: 99%
“…Lavage fluids were pooled, and cells were collected by centrifugation. Red blood cells were lysed by incubation in 0.17 M NH 4 Cl at 4°C for 10 min. Cells were washed with PBS and suspended in Dulbecco's modified Eagle's medium (Invitrogen Life Technologies, Carlsbad, CA) with 10% heat-inactivated fetal calf serum (Gemini Bioproducts, Woodland, CA), 10% NCTC-109 medium (Gibco, Carlsbad, CA), and 1% nonessential amino acids (Mediatech Cellgro, Washington, DC).…”
Section: Yeast Strain and Preparation Of Inocula For Infectionmentioning
confidence: 99%
See 1 more Smart Citation